Thank you for visiting nature.com. You are using a browser version with
limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off
compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site
Nanomedicine is a branch of medicine that applies the knowledge and tools of nanotechnology to the prevention and treatment of disease. Nanomedicine involves the use of nanoscale materials, such as biocompatible nanoparticles and nanorobots, for diagnosis, delivery, sensing or actuation purposes in a living organism.
The detection of small tumours with PET is significantly enhanced by temporal integration of the imaging signals, triggered by the acidic milieu of cancers, from pH-sensitive positron-emitting polycationic polymers.
Foreign body response can result in failure of biomaterials in vivo. Solvent-free crystals containing anti-fibrotic drugs now show the potential for long-term inhibition of fibrosis on a number of implantable devices in rodents and non-human primates.
We produced a human recombinant Hsp70-1A fused with the cell-penetrating peptide Tat (Tat-Hsp70-1A), that was neuroprotective in vitro against the dopaminergic toxin 6-hydroxydopamine (6-OHDA). We developed and characterized a Tat-Hsp70-1A delivery system by exploiting an injectable, biocompatible, biodegradable semi-interpenetrating polymer network composed of collagen (COLL) and low-molecular-weight hyaluronic acid (LMW HA), structured with gelatin particles. Tat-Hsp70-1A diffused from the selected COLL-LMW HA composites in an active form and protected dopaminergic cells and neurons in Parkinson’s disease (PD) models. Furthermore, Tat-Hsp70-loaded composites conveyed neuroprotection both at behavioral and dopaminergic neuronal level against striatal injection of 6-OHDA.
The first clinical success of immunotherapeutics for cancer treatment and the appreciation that tissue regeneration can be greatly improved by precisely and locally modulating the immune response are evidence that immunotherapy is poised to revolutionize the way we treat disease.
High-throughput nanoparticle synthesis combined with machine learning speeds up the exploration of structure–activity relationships for nanomedicines, as shown for spherical nucleic acids functioning as cancer-vaccine candidates.